R U Ostrovskaia Selected Research

GZR 123

1/2012	[The search of small molecules with antipsychotic activity on the background of neurotensin].
9/2009	[Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
1/2005	[Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R U Ostrovskaia Research Topics

Disease

5	Schizophrenia (Dementia Praecox) 01/2012 - 03/2003
4	Alzheimer Disease (Alzheimer's Disease) 12/2010 - 01/2005
3	Brain Ischemia (Cerebral Ischemia) 01/2012 - 09/2002
2	Thrombosis (Thrombus) 01/2013 - 03/2003
2	Hyperglycemia 01/2013 - 01/2010
2	Stroke (Strokes) 07/2006 - 03/2003
1	Body Weight (Weight, Body) 01/2013
1	Weight Loss (Weight Reduction) 01/2013
1	Psychotic Disorders (Schizoaffective Disorder) 09/2009
1	Autistic Disorder (Autism) 09/2009
1	Neurobehavioral Manifestations 09/2009
1	Ischemia 07/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2006
1	Infarction (Infarctions) 07/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2005
1	Epilepsy (Aura) 03/2003
1	Hypoxia (Hypoxemia) 03/2003
1	Wounds and Injuries (Trauma) 03/2003
1	Experimental Arthritis 03/2002
1	Inflammation (Inflammations) 03/2002
1	Catalepsy 01/2002
1	Tremor (Tremors) 03/2001
1	Amnesia (Dissociative Amnesia) 03/2000

Drug/Important Bio-Agent (IBA)

8	ethyl phenylacetyl-Pro-GlyIBA 12/2010 - 03/2001
7	DipeptidesIBA 01/2013 - 03/2002
5	Pharmaceutical PreparationsIBA 12/2010 - 03/2002
3	Streptozocin (Streptozotocin)FDA Link 01/2013 - 01/2010
3	GZR 123IBA 01/2012 - 01/2005
3	Antipsychotic Agents (Antipsychotics)IBA 09/2009 - 01/2005
2	Nerve Growth Factor (NGF)IBA 01/2013 - 01/2012
2	Apomorphine FDA Link 01/2012 - 01/2002
2	Nootropic Agents (Nootropics)IBA 01/2010 - 09/2005
2	Proline (L-Proline)FDA Link 07/2006 - 09/2005
1	Lysine (L-Lysine)FDA Link 01/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	Ketamine FDA LinkGeneric 01/2012
1	N-Methylaspartate (NMDA)IBA 01/2012
1	Dopamine (Intropin)FDA LinkGeneric 01/2012
1	tau Proteins (tau Protein)IBA 12/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2010
1	Nerve Growth Factors (Neurotrophins)IBA 12/2010
1	Phosphotransferases (Kinase)IBA 12/2010
1	Blood Glucose (Blood Sugar)IBA 01/2010
1	Glutamic Acid (Glutamate)FDA Link 09/2009
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 09/2005
1	AcidsIBA 03/2003
1	succinic semialdehydeIBA 03/2003
1	gamma-Aminobutyric Acid (GABA)IBA 03/2003
1	Neuroprotective AgentsIBA 09/2002
1	CarrageenanIBA 03/2002
1	Levodopa (L Dopa)FDA LinkGeneric 01/2002
1	Cholinergic Agents (Cholinergics)IBA 03/2001
1	Arecoline (Arecolin)IBA 03/2001
1	Scopolamine (Hyoscine)FDA Link 03/2000

Therapy/Procedure

1	Oral Administration 09/2009
1	Ligation 07/2006
1	Therapeutics 09/2005